Kathryn N. Phoenix

Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model

Kathryn N. Phoenix, Frank Vumbaca, Kevin P. Claffey · Breast Cancer Research and Treatment · 2008 · 175 citations · Full text

Medicine, Oncology, Pharmacology +14

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs

Kathryn N. Phoenix, Xinyuan Hong, Jennifer S. Tirnauer et al. · Breast Cancer Research and Treatment · 2011 · 151 citations

Life Sciences, Cell Biology, Oncology +16

Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1

John J. Peluso, Xiufang Liu, Melinda Saunders et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 146 citations · Full text

Medicine, Cancer Biology, Oncology +12

Double-Stranded RNA-Binding Protein Regulates Vascular Endothelial Growth Factor mRNA Stability, Translation, and Breast Cancer Angiogenesis

Frank Vumbaca, Kathryn N. Phoenix, Daniel Rodríguez‐Pinto et al. · Molecular and Cellular Biology · 2007 · 129 citations · Full text

Medicine, Cancer Biology, Molecular Biology +16

Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy

Kathryn N. Phoenix, Frank Vumbaca, Melissa M. Fox et al. · Breast Cancer Research and Treatment · 2009 · 97 citations

Medicine, Cancer Biology, Oncology +16